How promising are the latest monoclonal antibodies targeting amyloid-β for the treatment of early Alzheimer’s disease?

Overview of attention for article published in Expert Opinion on Emerging Drugs, January 2024

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (79th percentile)
Good Attention Score compared to outputs of the same age and source (66th percentile)

So far, Altmetric has seen 1 news story.

Beveridge J, Kaniecki E, Naidu A, Silverglate BD, Grossberg G.. Expert Opin Emerg Drugs.

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.